Want to see CAH full AI Analyst Report?
CAH Stock Chart & Stats
$213.99
-$0.20(-0.16%)
At close: 4:00 PM EST
$213.99
-$0.20(-0.16%)
Day’s Range― - ―
52-Week Range$137.75 - $243.21
Previous CloseN/A
Volume818.36K
Average Volume (3M)2.41M
Market Cap
$53.52B
Enterprise Value$55.01K
Total Cash (Recent Filing)$3.94B
Total Debt (Recent Filing)$8.92B
Price to Earnings (P/E)34.4
Beta0.32
Next Earnings
Aug 11, 2026EPS Estimate
2.42Next Dividend Ex-DateN/A
Dividend Yield0.91%
Share Statistics
EPS (TTM)6.56
Shares Outstanding234,205,860
10 Day Avg. Volume2,688,793
30 Day Avg. Volume2,413,283
Financial Highlights & Ratios
PEG Ratio0.30
Price to Book (P/B)-14.56
Price to Sales (P/S)0.18
P/FCF Ratio21.89
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$249.33Price Target Upside16.52% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
EPS Forecast (FY)12.07
Revenue Forecast (FY)$276.61B
Bulls Say, Bears Say
Bulls Say
Free Cash Flow StrengthSustained, large free cash flow provides durable financial flexibility: it funds buybacks, debt paydown and operating investments without relying on equity markets. Even with FCF volatility, near-term guidance and strong TTM cash imply ongoing capacity to support strategic priorities and obligations.
Improving Revenue & ProfitabilityBroad-based top-line expansion alongside outsized non‑GAAP EPS improvement and raised guidance indicates durable operational leverage. Consistent revenue growth and margin expansion across quarters reflect scalable distribution economics and improved execution rather than one-off timing effects.
Diversified Growth BusinessesGrowing specialty, at‑home and precision health businesses increase revenue mix diversity and higher-margin exposure. These secular growth franchises reduce dependence on low‑margin commodity distribution and support more resilient long‑term profit growth as they scale and integrate acquisitions.
Bears Say
Negative Equity / LeveragePersistently negative equity materially weakens the balance sheet cushion and distorts leverage metrics, reducing resilience to shocks. High absolute debt combined with limited equity buffer constrains financial flexibility for large capital actions and increases refinancing and covenant risks over the medium term.
Structurally Thin MarginsVery low distribution margins make earnings highly sensitive to cost pressure, pricing shifts, and mix changes. Even modest tariff, SG&A, or reimbursement headwinds can compress profits materially, so margin sustainability requires consistent scale, tight cost control, and favorable contract terms.
Tariff & Regulatory UncertaintyMaterial tariff exposure and uncertain refund outcomes create ongoing earnings volatility and operational risk in medical products distribution. Policy and legal timing is unpredictable, meaning realized recoveries and customer sharing could differ materially from management expectations, pressuring margins.
Cardinal Health News
CAH FAQ
What was Cardinal Health’s price range in the past 12 months?
Cardinal Health lowest stock price was $137.75 and its highest was $243.21 in the past 12 months.
What is Cardinal Health’s market cap?
Cardinal Health’s market cap is $53.52B.
When is Cardinal Health’s upcoming earnings report date?
Cardinal Health’s upcoming earnings report date is Aug 11, 2026 which is in 21 days.
How were Cardinal Health’s earnings last quarter?
Cardinal Health released its earnings results on Apr 30, 2026. The company reported $3.17 earnings per share for the quarter, beating the consensus estimate of $2.795 by $0.375.
Is Cardinal Health overvalued?
According to Wall Street analysts Cardinal Health’s price is currently Undervalued.
Does Cardinal Health pay dividends?
Cardinal Health pays a Quarterly dividend of $0.516 which represents an annual dividend yield of 0.91%. See more information on Cardinal Health dividends here
What is Cardinal Health’s EPS estimate?
Cardinal Health’s EPS estimate is 2.42.
How many shares outstanding does Cardinal Health have?
Cardinal Health has 234,205,860 shares outstanding.
What happened to Cardinal Health’s price movement after its last earnings report?
Cardinal Health reported an EPS of $3.17 in its last earnings report, beating expectations of $2.795. Following the earnings report the stock price went down -4.901%.
Which hedge fund is a major shareholder of Cardinal Health?
Currently, no hedge funds are holding shares in CAH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cardinal Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$249.33 (16.52% Upside)
$249.33 (16.52% Upside)
Blogger Sentiment
Bullish
CAH Sentiment 70%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Decreased
By 788.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 2.3%
Last 30 Days ▲ 2.3%
News Sentiment
Bullish
Bullish news 67%
Bearish news 33%
Bearish news 33%
Technicals
SMA
Positive
20 days / 200 days
Momentum
44.79%
12-Months-Change
Fundamentals
Return on Equity
0.91%
Trailing 12-Months
Asset Growth
13.67%
Trailing 12-Months
Company Description
Cardinal Health
Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
CAH Revenue Breakdown
91.94% Pharmaceutical and Specialty Solutions
5.68% Global Medical Products and Distribution
2.42% Other
-0.04% Corporate

CAH Stock 12 Month Forecast
Average Price Target
$249.33
▲(16.52% Upside)
Technical Analysis
Ownership Overview
0.25% Insiders
22.70% Mutual Funds
0.66% Other Institutional Investors
47.41% Public Companies and Individual Investors








